Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafael Simó

Showing results (51-60 of 358) with videos related to

Pageof 36
Sort By:
Diabetologia|July 22, 2018
Neurodegeneration in diabetic retinopathy: does it really matter?Rafael Simó, Alan W Stitt, Thomas W Gardner
Diabetologia|June 20, 2020
Diabetic retinopathy: looking beyond the eyesRafael Simó, Coen D A Stehouwer, Angelo Avogaro
World Journal of Diabetes|May 4, 2011
Neurodegeneration: An early event of diabetic retinopathyMarta Villarroel, Andreea Ciudin, Cristina Hernández, et al.
The Journal of Clinical Endocrinology and Metabolism|July 9, 2004
Usefulness of homeostasis model assessment for identifying subjects at risk for hypoglycemia failure during the insulin hypoglycemia testGemma Francisco, Cristina Hernández, Rosa Galard, et al.
Diabetes Care|March 29, 2005
Lipoprotein(a) as a risk factor for cardiovascular mortality in type 2 diabetic patients: a 10-year follow-up studyCristina Hernández, Gemma Francisco, Pilar Chacón, et al.
Diabetes Care|April 29, 2006
Proinflammatory cytokines, insulin resistance, and insulin secretion in chronic hepatitis C patients: A case-control studyAlbert Lecube, Cristina Hernández, Joan Genescà, et al.
Diabetes Care|April 29, 2006
Glucose abnormalities in patients with hepatitis C virus infection: Epidemiology and pathogenesisAlbert Lecube, Cristina Hernández, Joan Genescà, et al.
Diabetes Care|March 22, 2014
Ocular Anti-VEGF therapy for diabetic retinopathy: the role of VEGF in the pathogenesis of diabetic retinopathyRafael Simó, Jeffrey M Sundstrom, David A Antonetti
Pharmaceuticals (Basel, Switzerland)|January 8, 2025
Ocular and Plasma Pharmacokinetics of Sitagliptin Eye Drops: Preclinical DataCristina Hernández, Hugo Ramos, Anne Létondor, et al.
Acta Diabetologica|February 18, 2017
Cognitive impairment and dementia: a new emerging complication of type 2 diabetes-The diabetologist's perspectiveRafael Simó, Andreea Ciudin, Olga Simó-Servat, et al.
Pageof 36

Showing results (51-60 of 358) with videos related to

Sort By:
Pageof 36
Diabetologia|July 22, 2018
Neurodegeneration in diabetic retinopathy: does it really matter?Rafael Simó, Alan W Stitt, Thomas W Gardner
Diabetologia|June 20, 2020
Diabetic retinopathy: looking beyond the eyesRafael Simó, Coen D A Stehouwer, Angelo Avogaro
World Journal of Diabetes|May 4, 2011
Neurodegeneration: An early event of diabetic retinopathyMarta Villarroel, Andreea Ciudin, Cristina Hernández, et al.
The Journal of Clinical Endocrinology and Metabolism|July 9, 2004
Usefulness of homeostasis model assessment for identifying subjects at risk for hypoglycemia failure during the insulin hypoglycemia testGemma Francisco, Cristina Hernández, Rosa Galard, et al.
Diabetes Care|March 29, 2005
Lipoprotein(a) as a risk factor for cardiovascular mortality in type 2 diabetic patients: a 10-year follow-up studyCristina Hernández, Gemma Francisco, Pilar Chacón, et al.
Diabetes Care|April 29, 2006
Proinflammatory cytokines, insulin resistance, and insulin secretion in chronic hepatitis C patients: A case-control studyAlbert Lecube, Cristina Hernández, Joan Genescà, et al.
Diabetes Care|April 29, 2006
Glucose abnormalities in patients with hepatitis C virus infection: Epidemiology and pathogenesisAlbert Lecube, Cristina Hernández, Joan Genescà, et al.
Diabetes Care|March 22, 2014
Ocular Anti-VEGF therapy for diabetic retinopathy: the role of VEGF in the pathogenesis of diabetic retinopathyRafael Simó, Jeffrey M Sundstrom, David A Antonetti
Pharmaceuticals (Basel, Switzerland)|January 8, 2025
Ocular and Plasma Pharmacokinetics of Sitagliptin Eye Drops: Preclinical DataCristina Hernández, Hugo Ramos, Anne Létondor, et al.
Acta Diabetologica|February 18, 2017
Cognitive impairment and dementia: a new emerging complication of type 2 diabetes-The diabetologist's perspectiveRafael Simó, Andreea Ciudin, Olga Simó-Servat, et al.
Pageof 36